Maternal hyperthermia induced birth defects is a rare maternal disease-related embryofetopathy characterized by variable developmental anomalies of the fetus due to teratogenic effect of elevated mate...
Comprehensive, easy-to-understand information about this condition
How we create this content →Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Connect with organizations supporting the maternal hyperthermia induced birth defects community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
1 peer-reviewed source from PubMed
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 1 company has orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning maternal hyperthermia induced birth defects
Updated May 21, 2009
Recent data highlights the ongoing issue of alcohol consumption during pregnancy, which is a significant contributor to birth defects. Awareness campaigns are crucial to address this public health concern.
A CDC study reveals that infants conceived through Assisted Reproductive Technology (ART) face a two to four times higher risk of specific birth defects compared to naturally conceived children. This finding underscores the need for further investigation into the safety of ART.
A study published in the American Journal of Obstetrics and Gynecology reveals that women diagnosed with diabetes before pregnancy face a three to four times higher risk of having children with birth defects. This research underscores the importance of managing pre-pregnancy diabetes to mitigate risks.
A new CDC study indicates that the use of antidepressants during pregnancy poses few risks of birth defects. The findings encourage women to consult their healthcare providers to weigh the risks and benefits of treatment.